Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN. Cardiac sarcoidosis. Am Heart J 2009;157:9‐21.

Article  CAS  PubMed  Google Scholar 

Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011;183:1524‐30.

Article  PubMed  PubMed Central  Google Scholar 

Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455‐69.

Article  CAS  PubMed  Google Scholar 

Hiraga H, Yuwai K, Hiroe M. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord 2007;27:89‐102.

Google Scholar 

Yoshinaga K, Miyagawa M, Kiso K, Ishida Y. Japanese Guidelines for Cardiac Sarcoidosis. Ann Nucl Cardiol 2017;3:121‐4.

Article  Google Scholar 

Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305‐23.

Article  PubMed  Google Scholar 

Holzmann M, Nicko A, Kühl U, Noutsias M, Poller W, Hoffman W, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008;118:1722‐8.

Article  PubMed  Google Scholar 

Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease. Eur Heart J 2007;28:3076‐93.

Article  PubMed  Google Scholar 

Lynch JP 3rd, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med 2014;35:372‐90.

Article  PubMed  PubMed Central  Google Scholar 

Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326‐8.

Article  PubMed  Google Scholar 

Simonen P, Lehtonen J, Kandolin R, Schildt J, Marjasuo S, Miettinen H, et al. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis. Am J Cardiol 2015;116:1581‐5.

Article  PubMed  Google Scholar 

Higashi H, Inaba S, Iio C, Inoue K, Ogimoto A, Miyagawa M, et al. Features and clinical impact of extra-cardiac lesions with 18F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis. Int J Cardiol Heart Vasc 2020;30:100587.

PubMed  PubMed Central  Google Scholar 

Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011;270:461‐8.

Article  CAS  PubMed  Google Scholar 

Nguyen BD. F-18 FDG PET imaging of disseminated sarcoidosis. Clin Nucl Med 2007;32:53‐4.

Article  PubMed  Google Scholar 

Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007;132:1949‐53.

Article  PubMed  Google Scholar 

Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153‐65.

Article  CAS  PubMed  Google Scholar 

Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885‐9.

Article  CAS  PubMed  Google Scholar 

Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J, Dwivedi G. The utility of whole body F-18 FDG PET-CT in diagnosing isolated cardiac sarcoidosis: The western Australian cardiac sarcoid study. Heart Lung Circ 2020;29:e1‐6.

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Popcock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344‐9.

Article  Google Scholar 

Larson SR, et al. Characterization of a highly effective preparation for suppression of myocardial glucose utilization. J Nucl Cardiol 2019;27:849.

Article  PubMed  PubMed Central  Google Scholar 

Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of F-18 FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017;58:1341‐53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawada S, Suzuki Y, Hinohara S, Koide S, Ono Y, Ashikaga H. Cancer screening with PET: Advantages and limitations. Rinsho Byori 2007;55:656‐67.

PubMed  Google Scholar 

Terauchi T, Murano T, Daisaki H, Kanou D, Shoda H, Kakinuma R, et al. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: A preliminary report. Ann Nucl Med 2008;22:379‐85.

Article  PubMed  Google Scholar